![Sean Buckley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Buckley
Directeur Technique/Scientifique/R&D chez
IMMUNOCORE HOLDINGS PLC
Profil
Sean D.
Buckley is Chief Information Officer & Vice President at Immunocore Holdings Plc since 2021.
Former roles include Chief Financial Officer & Senior Vice President at Longevity Health Holdings, Inc. in 2022, Chief Business Officer & Vice President at Castle Creek Biosciences, Inc. from 2019 to 2021, Chief Financial Officer & Vice President at Fibrocell Science, Inc. from 2017 to 2019, and Manager-Information Technology at Toray Advanced Composites UK Ltd. Education includes an undergraduate degree from The University of Hull and an MBA from Robert H.
Smith School of Business.
Postes actifs de Sean Buckley
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 01/09/2021 |
Anciens postes connus de Sean Buckley
| Sociétés | Poste | Fin |
|---|---|---|
| LONGEVITY HEALTH HOLDINGS, INC. | Directeur Financier/CFO | 01/09/2022 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Corporate Officer/Principal | 01/01/2021 |
| FIBROCELL SCIENCE, INC. | Directeur Financier/CFO | 01/12/2019 |
Toray Advanced Composites UK Ltd.
 Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Manufactures composites for industrial and automotive markets | Directeur Technique/Scientifique/R&D | - |
Formation de Sean Buckley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
The University of Hull
 The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert H. Smith School of Business
 Robert H. Smith School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Toray Advanced Composites UK Ltd.
Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Manufactures composites for industrial and automotive markets | Process Industries |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Carmell Therapeutics Corp.
 Carmell Therapeutics Corp. Financial ConglomeratesFinance Manufactures cosmetics | Finance |
